Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Change in Acquisitions & Divestments (2010 - 2026)

Vericel (VCEL) posted Change in Acquisitions & Divestments of $11.0 million for Q2 2026, down 23.07% sequentially from $14.2 million in Q1 2026, and down 25.17% YoY from $14.6 million in Q2 2025.

Analysis

Vericel (VCEL) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

Vericel has reported Change in Acquisitions & Divestments for 10 years, with the latest figure at $11.0 million in Q2 2026.

  • Quarterly Change in Acquisitions & Divestments fell 25.17% year-over-year to $11.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $53.7 million (down 5.86% YoY) and the FY2025 annual result came in at $55.6 million, up 4.6% from the prior year.
  • Change in Acquisitions & Divestments fell to $11.0 million in Q2 2026 per VCEL's latest filing, from $14.2 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $21.5 million in Q1 2023 and troughed at $5.0 million in Q4 2022.
  • A 5-year average of $14.1 million and a median of $14.4 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments sank 79.8% in 2022, then soared 326.5% in 2023.
  • Over 5 years, Change in Acquisitions & Divestments stood at $5.0 million in 2022, then jumped by 274.36% to $18.7 million in 2023, then fell by 21.28% to $14.7 million in 2024, then declined by 0.58% to $14.6 million in 2025, then dropped by 25.17% to $11.0 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $11.0 million, $14.2 million, and $14.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.96 Mn
Mar 31, 2026 14.25 Mn
Dec 31, 2025 14.65 Mn
Sep 30, 2025 13.80 Mn
Jun 30, 2025 14.65 Mn
Mar 31, 2025 12.50 Mn
Dec 31, 2024 14.74 Mn
Sep 30, 2024 15.11 Mn
Jun 30, 2024 12.19 Mn
Mar 31, 2024 11.12 Mn
Dec 31, 2023 18.72 Mn
Sep 30, 2023 18.85 Mn
Jun 30, 2023 20.54 Mn
Mar 31, 2023 21.50 Mn
Dec 31, 2022 5.00 Mn
Sep 30, 2022 9.60 Mn
Jun 30, 2022 21.30 Mn
Mar 31, 2022 5.04 Mn
Dec 31, 2021 13.52 Mn
Sep 30, 2021 18.26 Mn